thalidomide
Showing 1 - 25 of 271
Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)
Completed
- Transfusion-dependent Beta-Thalassemia
- Thalidomide
-
Peshawar, Khyber Pakhtunkhwa, PakistanBlood Care Clinic
Nov 19, 2023
Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)
Not yet recruiting
- Pancreatic Cancer Stage IV
- Chemotherapy-induced Nausea and Vomiting
- Thalidomide
- +2 more
- (no location specified)
Aug 24, 2023
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- dexamethasone
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 30, 2022
Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Miami (Thalidomide)
Active, not recruiting
- Mantle Cell Lymphoma
- Non-Hodgkin's Lymphoma
- Thalidomide
-
Miami, FloridaUniversity of Miami
Sep 14, 2022
Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)
Active, not recruiting
- Myelofibrosis
- Ruxolitinib
- Thalidomide
-
Middletown, New Jersey
- +6 more
Aug 23, 2022
Chronic Lymphocytic Leukemia Trial in New York (thalidomide, lenalidomide, rituximab)
Completed
- Chronic Lymphocytic Leukemia
- thalidomide
- +2 more
-
New York, New YorkWeill Cornell Medical College
Dec 23, 2021
Metastatic Colorectal Cancer Trial in Fuzhou (Thalidomide, TAS-102)
Recruiting
- Metastatic Colorectal Cancer
- Thalidomide
- TAS-102
-
Fuzhou, Fujian, China
- +5 more
Mar 4, 2022
Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Mar 3, 2022
Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)
Recruiting
- Plasma Cell Myeloma
- Renal Failure
- Bortezomib
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 13, 2022
HIV Trial in United States (Thalidomide)
Completed
- HIV Infections
- Thalidomide
-
Aurora, Colorado
- +5 more
Oct 27, 2021
Brain and CNS Tumors Trial in United States (procarbazine HCl, thalidomide)
Completed
- Brain and Central Nervous System Tumors
- procarbazine hydrochloride
- thalidomide
-
Decatur, Illinois
- +4 more
Sep 7, 2021
Brain and CNS Tumors, Solid Tumor Trial in United States (temozolomide, thalidomide, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- Unspecified Adult Solid Tumor, Protocol Specific
- temozolomide
- +2 more
-
Decatur, Illinois
- +4 more
Sep 7, 2021
Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- Neurotoxicity
- bortezomib
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 17, 2021
Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)
Completed
- Multiple Myeloma
- Chronic Kidney Disease
- Bortezomib
- +3 more
-
Basingstoke, United Kingdom
- +8 more
Jan 26, 2022
Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous Lupus Trial in São Paulo (Thalidomide, Hydroxychloroquine reduced,
Completed
- Systemic Lupus Erythematosus (SLE)
- +2 more
- Thalidomide
- +2 more
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021
Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +11 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 1, 2022
Multiple Myeloma Trial in Chengdu (Selinexor, Thalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Selinexor
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 13, 2021
Brain and CNS Tumors, Glioblastoma Multiforme Trial in United States (Celecoxib, Isotretinoin, Temozolomide)
Completed
- Brain and Central Nervous System Tumors
- Glioblastoma Multiforme
- Celecoxib
- +3 more
-
Fort Smith, Arkansas
- +11 more
Sep 21, 2021
Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
-
Duarte, California
- +21 more
Jan 17, 2023
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)
Recruiting
- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- pegaspargase
- +5 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021
Chronic Radiation Proctitis Trial (Thalidomide)
Unknown status
- Chronic Radiation Proctitis
- Thalidomide
- (no location specified)
Dec 19, 2020
Amyloidosis Trial in United Kingdom (Carfilzomib, Thalidomide, Dexamethasone)
Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)
Active, not recruiting
- Myeloma
- Melphalan
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Dec 1, 2021